Boston Biomedical Secures NIH Grant to Develop Asymmetric RNAi Technology for Research Apps

Meanwhile, the status of a start-up founded to develop the technology for therapeutic applications remains in question.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.